Literature DB >> 13124503

An antithrombin reaction to prothrombin activation.

W H Seegers, J F Johnson, C Fell.   

Abstract

Entities:  

Keywords:  PROTHROMBIN; THROMBIN

Mesh:

Substances:

Year:  1954        PMID: 13124503     DOI: 10.1152/ajplegacy.1953.176.1.97

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


× No keyword cloud information.
  16 in total

1.  [INACTIVATION OF BLOOD THROMBOKINASE IN THE PRESENCE OF PROTHROMBIN AND FACTOR VIII].

Authors:  K SCHIMPF; G BRIEGER; N O OSAMO
Journal:  Klin Wochenschr       Date:  1964-02-01

2.  [THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM].

Authors:  K SCHIMPF; A CIBELIUS; R MARDINI
Journal:  Klin Wochenschr       Date:  1964-07-01

3.  The maintenance of a sustained thrombolytic state in man. I. Induction and effects.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

4.  [New determination method and clinical significance of antithrombin].

Authors:  J JURGENS
Journal:  Klin Wochenschr       Date:  1957-03-15

5.  [New concepts on the mechanism of blood coagulation].

Authors:  R MARBET; A WINTERSTEIN
Journal:  Experientia       Date:  1954-07-15

6.  [Antithrombin activities of plasma in liver disease and obstructive jaundice].

Authors:  G SOKAL; F SCHMID; M H HORDER
Journal:  Klin Wochenschr       Date:  1955-10-15

7.  [Blood platelets and coagulationactive plasma proteins. A short summary of their function and pathology].

Authors:  E MAMMEN; R GROSS
Journal:  Blut       Date:  1962-05

8.  Binding of alpha-thrombin to fibrin depends on the quality of the fibrin network.

Authors:  H Bänninger; B Lämmle; M Furlan
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

Review 9.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

10.  [Blood coagulation disorder in neonatal hemolytic disease, released by an inhibitor in the second clotting phase].

Authors:  H Haupt
Journal:  Klin Wochenschr       Date:  1966-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.